Fesoterodine Fumarate Tablet, Film Coated, Extended Release
Product Images NDC 70771-1168

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fesoterodine Fumarate (NDC 70771-1168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fesoterodine Er Tablets, 4 mg (9b26e45d Eef8 463b 9773 9ce326ecb333 06)

This is a 90 tablet prescription of Fesoterodine Fumarate Extended-Release Tablets containing 4mg Fesoterodine Fumarate in each tablet. The usual dosage information is available in the package insert. The medication should be stored at room temperature. Caution must be taken to keep the medicine out of reach of children. Pharmacist is instructed to provide separate patient information leaflet with every prescription. The medication is manufactured in India by Caa Healthcare Ltd.*

FDA Label Image

Fesoterodine Er Tablets, 8 mg (9b26e45d Eef8 463b 9773 9ce326ecb333 07)

This is the label of a medication called Fesoterodine Fumarate which comes in extended-release tablets. It contains 5mg of the fumarate. The usual dosage should be referred to the package insert for prescribing information. The medication should be stored at a temperature of 20-25°C (68-77°F) and protected from moisture. It is manufactured by Caia Healthcare Ltd in India. The label advises the pharmacist to dispense the patient information separately to each patient and reminds to keep the drug out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.